Literature DB >> 26547755

The Lactulose Breath Test in Irritable Bowel Syndrome: Is It All Hot Air?

Rebecca E Burgell1, Peter R Gibson2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26547755     DOI： 10.1007/s10620-015-3956-6

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  10 in total

Review 1.  The concept of small intestinal bacterial overgrowth in relation to functional gastrointestinal disorders.

Authors:  Peter R Gibson; Jacqueline S Barrett
Journal:  Nutrition       Date:  2010-04-24       Impact factor: 4.008

Review 2.  A systematic review of diagnostic tests for small intestinal bacterial overgrowth.

Authors:  Reza Khoshini; Sun-Chuan Dai; Sheila Lezcano; Mark Pimentel
Journal:  Dig Dis Sci       Date:  2008-06       Impact factor: 3.199

Review 3.  Breath testing for small intestinal bacterial overgrowth: maximizing test accuracy.

Authors:  Richard J Saad; William D Chey
Journal:  Clin Gastroenterol Hepatol       Date:  2013-10-01       Impact factor: 11.382

4.  Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome.

Authors:  M Pimentel; E J Chow; H C Lin
Journal:  Am J Gastroenterol       Date:  2000-12       Impact factor: 10.864

5.  Breath tests in the diagnosis of small intestinal bacterial overgrowth in patients with irritable bowel syndrome in comparison with quantitative upper gut aspirate culture.

Authors:  Uday C Ghoshal; Deepakshi Srivastava; Ujjala Ghoshal; Asha Misra
Journal:  Eur J Gastroenterol Hepatol       Date:  2014-07       Impact factor: 2.566

6.  Rifaximin therapy for patients with irritable bowel syndrome without constipation.

Authors:  Mark Pimentel; Anthony Lembo; William D Chey; Salam Zakko; Yehuda Ringel; Jing Yu; Shadreck M Mareya; Audrey L Shaw; Enoch Bortey; William P Forbes
Journal:  N Engl J Med       Date:  2011-01-06       Impact factor: 91.245

7.  An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota.

Authors:  Ian B Jeffery; Paul W O'Toole; Lena Öhman; Marcus J Claesson; Jennifer Deane; Eamonn M M Quigley; Magnus Simrén
Journal:  Gut       Date:  2011-12-16       Impact factor: 23.059

8.  Combined oro-caecal scintigraphy and lactulose hydrogen breath testing demonstrate that breath testing detects oro-caecal transit, not small intestinal bacterial overgrowth in patients with IBS.

Authors:  Derek Yu; Frank Cheeseman; Stephen Vanner
Journal:  Gut       Date:  2010-11-26       Impact factor: 23.059

9.  Predicting a Response to Antibiotics in Patients with the Irritable Bowel Syndrome.

Authors:  Rafid Kasir; Salam Zakko; Philip Zakko; Michael Adler; Aaron Lee; Sachin Dhingra; Cecile Guttermuth
Journal:  Dig Dis Sci       Date:  2015-09-11       Impact factor: 3.199

10.  Determination of rifaximin treatment period according to lactulose breath test values in nonconstipated irritable bowel syndrome subjects.

Authors:  Suhyun Bae; Kwang Jae Lee; Young-Sang Kim; Kyu-Nam Kim
Journal:  J Korean Med Sci       Date:  2015-05-13       Impact factor: 2.153
  10 in total
  3 in total

1.  Poor reproducibility of breath hydrogen testing: Implications for its application in functional bowel disorders.

Authors:  Chu K Yao; Caroline J Tuck; Jacqueline S Barrett; Kim Ek Canale; Hamish L Philpott; Peter R Gibson
Journal:  United European Gastroenterol J       Date:  2016-07-07       Impact factor: 4.623

2.  Obesity Is Inversely Related to Hydrogen-Producing Small Intestinal Bacterial Overgrowth in Non-Constipation Irritable Bowel Syndrome.

Authors:  Seung Eun Jung; Nam Seok Joo; Kyung Sun Han; Kyu Nam Kim
Journal:  J Korean Med Sci       Date:  2017-06       Impact factor: 2.153

3.  Dietary exclusion of fructose and lactose after positive breath tests improved rapid-transit constipation in children.

Authors:  Kasturi Waingankar; Christoper Lai; Vishal Punwani; Jeremy Wong; John M Hutson; Bridget R Southwell
Journal:  JGH Open       Date:  2018-08-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.